TriSalus Life Sciences, Inc. (TLSIW) Capital expenditures 2022–2025
TriSalus Life Sciences, Inc. (TLSIW) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$918,000FY2025 · since FY2022: $655,000 → $918,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $918,000 | +166.1% |
| FY2024 | $345,000 | -41.3% |
| FY2023 | $588,000 | -10.2% |
| FY2022 | $655,000 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice
More TLSIW financial trends
TLSIW RevenueTLSIW Net incomeTLSIW Net marginTLSIW Gross profitTLSIW Gross marginTLSIW Operating incomeTLSIW Operating marginTLSIW Operating cash flowTLSIW Free cash flowTLSIW Return on equityTLSIW Stock buybacksTLSIW Dividends paidTLSIW Total assetsTLSIW Total liabilitiesTLSIW Shareholders’ equityTLSIW overview →